Disease/Infection News

RSS

SCD health disparities tied to community factors

A new study finds that preschool-aged children with sickle cell disease (SCD) who live in food deserts and have limited access to transportation are at greater risk for acute complications and hospitalizations, despite receiving free evidence-based therapy and social support, according to results published today in Blood Advances.

8 Oct 2024

Doxycycline increases antimicrobial resistance in the gut without disrupting microbiome diversity

Doxycycline post-exposure prophylaxis increases tetracycline resistance genes in the gut, without significantly affecting microbiome diversity in men who have sex with men and transgender women.

7 Oct 2024

Researchers uncover how senescent cells can both harm and heal in liver disease

Researchers developed novel genetic tools to trace, ablate, and manipulate p16^Ink4a+^ senescent cells, revealing their distinct roles in liver fibrosis and repair. Senescent macrophages promote fibrosis, while endothelial cells aid in tissue recovery.

7 Oct 2024

UMass Amherst researcher receives $2.2 million grant to study tuberculosis response

The National Institutes of Health recently awarded $2.2 million to Alissa Rothchild, assistant professor in the Department of Veterinary and Animal Sciences at the University of Massachusetts Amherst and an expert in tuberculosis (TB) immunology, to study the very first cells that respond to Mycobacterium tuberculosis (Mtb), the bacteria causing TB.

7 Oct 2024

When CDK12/13 stalls, healthy prostate cells take a malignant turn

CDK12 is established as a tumor suppressor in prostate cancer, with its loss driving aggressive disease and creating vulnerabilities for targeted therapies.

7 Oct 2024

Antigenic mapping sheds light on SARS-CoV-2 immunity differences

A person's immune response to variants of SARS-CoV-2, the virus that causes COVID-19, depends on their previous exposure - and differences in the focus of immune responses will help scientists understand how to optimise vaccines in the future to provide broad protection.

7 Oct 2024

COVID-19 increases chronic fatigue risk

Study reveals that COVID-19 significantly increases the risk of chronic fatigue syndrome, with specific populations, such as older adults, Asians, and non-hospitalized patients, at higher risk.

7 Oct 2024

Researchers link air pollution to cerebral atrophy but find no impact on cognitive function

Exposure to mid- to high-range PM2.5 is linked to cerebral atrophy, but there is no significant impact on cognitive function. The findings suggest that urbanization plays a role in modulating the effects of air pollution on brain structure.

6 Oct 2024

Pasteurization effectively reduces H5N1 virus in milk but further testing is essential

Research explores the resilience of the H5N1 influenza virus in milk under pasteurization conditions, showing effective viral inactivation at standard temperatures but highlighting the need for further real-world testing.

6 Oct 2024

Study reveals high effectiveness of flu vaccines in children but highlights challenges with certain subtypes

Study found that influenza vaccination is highly effective in preventing infection and hospitalization in children, though efficacy against certain subtypes like H3N2 remains limited due to small sample sizes.

6 Oct 2024

Global experts gather in Brisbane for scientific meeting dedicated to influenza

More than 1,400 experts have visited Brisbane for the world's only scientific meeting dedicated to influenza.

4 Oct 2024

New strategy uses bacteriophages to combat drug-resistant infections

Researchers have a new battle tactic to fight drug-resistant bacterial infections. Their strategy involves using collections of bacteriophages, viruses that naturally attack bacteria.

4 Oct 2024

WHO lists first mpox in vitro diagnostic test under Emergency Use Listing

The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing.

4 Oct 2024

Thousands could have been saved during the pandemic with expanded use of convalescent plasma

A new study led by researchers at Johns Hopkins Bloomberg School of Public Health estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent plasma had been used more broadly, particularly in outpatients at high risk for severe disease and in hospitalized patients during their first few days of admission.

4 Oct 2024

Study highlights benefits and risks of doxy-PEP for STI prevention

Taking a dose of the oral antibiotic doxycycline after a high-risk sexual encounter has dramatically reduced the incidence of sexually transmitted infections (STIs) in places where the strategy is being tried.

4 Oct 2024

Researchers probe environmental causes of preterm birth with $2.8M grant

A new grant will help Wayne State University researchers explore the links between bacterial infections, the environmental factors that increase their susceptibility and the risk of preterm birth.

4 Oct 2024

Oropouche virus spreads in South America as scientists warn of potential outbreaks in the U.S.

Researchers review the reemergence and range expansion of Oropouche virus in South America, highlighting risks of spread to the U.S. and need for improved diagnostic tests. Over 9,000 cases and two deaths were reported in 2024.

4 Oct 2024

Study confirms flu vaccine effectiveness against A H1N1 in young children

A study published on Eurosurveillance has demonstrated that Spain's influenza vaccination campaign for children aged 6-59 months during the 2023/24 season was effective in preventing acute respiratory infections (ARI) and hospitalization, as vaccination was recommended for this age group at the national level for the first time.

4 Oct 2024

Lithium aspartate fails to improve long COVID symptoms, but higher doses may hold promise

Lithium aspartate at 10-15 mg/d is ineffective for treating cognitive dysfunction and fatigue in long COVID, but higher doses may offer potential benefits based on a small follow-up study.

3 Oct 2024

Mild COVID-19 disrupts brain connectivity and reduces memory function in adolescents and young adults

Study reveals localized brain changes in adolescents and young adults post-COVID, including reduced hippocampal volume and disrupted connectivity, correlating with impaired working memory. These findings highlight the importance of understanding long-term cognitive effects of mild COVID-19.

3 Oct 2024

Previous
1
...
35
36
37
38
39
40
41
...
2465
Next

Disease/Infection News

SCD health disparities tied to community factors

Doxycycline increases antimicrobial resistance in the gut without disrupting microbiome diversity

Researchers uncover how senescent cells can both harm and heal in liver disease

UMass Amherst researcher receives $2.2 million grant to study tuberculosis response

When CDK12/13 stalls, healthy prostate cells take a malignant turn

Antigenic mapping sheds light on SARS-CoV-2 immunity differences

COVID-19 increases chronic fatigue risk

Researchers link air pollution to cerebral atrophy but find no impact on cognitive function

Pasteurization effectively reduces H5N1 virus in milk but further testing is essential

Study reveals high effectiveness of flu vaccines in children but highlights challenges with certain subtypes

Global experts gather in Brisbane for scientific meeting dedicated to influenza

New strategy uses bacteriophages to combat drug-resistant infections

WHO lists first mpox in vitro diagnostic test under Emergency Use Listing

Thousands could have been saved during the pandemic with expanded use of convalescent plasma

Study highlights benefits and risks of doxy-PEP for STI prevention

Researchers probe environmental causes of preterm birth with $2.8M grant

Oropouche virus spreads in South America as scientists warn of potential outbreaks in the U.S.

Study confirms flu vaccine effectiveness against A H1N1 in young children

Lithium aspartate fails to improve long COVID symptoms, but higher doses may hold promise

Mild COVID-19 disrupts brain connectivity and reduces memory function in adolescents and young adults

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News